The 20 Best Atherosclerosis Doctors in The United States

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Khurram Nasir is a Cardiologist in Houston, Texas. Dr. Nasir is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Heart Failure, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the Mallinckrodt Professor of Medicine at Harvard Medical School (HMS).Dr. Libby received his medical degree from the University of California, San Diego School of Medicine. He completed a residency in internal medicine and a fellowship in cardiovascular disease at Peter Bent Brigham Hospital (now BWH). He also completed a research fellowship in cellular physiology at HMS. Dr. Libby is board certified in internal medicine and cardiovascular disease.The author of some 400 original peer-reviewed publications, some 450 reviews, chapters, or other publications, Dr. Libby also serves as an Editor of the leading textbook of cardiovascular medicine.  Dr. Libby's clinical and research interests include vascular biology, atherosclerosis and preventive cardiology. The research laboratory that Dr. Libby directs studies the messengers created by the body that may produce arterial plaque and blockages, as well as normal and abnormal function of smooth muscle and endothelial cells. Dr. Libby is perennially named a top cardiologist. His research has received funding from the American Heart Association and National Institutes of Health. Dr. Libby has received research recognitions on four continents including the highest research awards from the American Heart Association and American College of Cardiology, the Gold Medal of the European Society of Cardiology, the Anitschkow award from the European Atherosclerosis Society, The Ernst Jung Gold Medal for Medicine, and the Earl Benditt award for vascular biology. Dr. Libby is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Abdominal Aortic Aneurysm (AAA), Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

I am an interventional cardiologist and researcher who has been at Duke for nearly 20 years. I enjoy being at Duke because of the “family” I get to work with every day. When we are able to make a patient feel better through teamwork; it’s a great feeling. I chose cardiology as my specialty because of the chance to make a difference in someone’s life in real time. When someone is having a heart attack, they are relying on you to come to their aid quickly. At that moment, I get to apply science to save a life, while learning more about what we can do to help improve people’s lives in the future. In that way, medicine also gives me the chance to learn from my patients and apply what I find to benefit the greater good. I find that whole process is exciting. When I am not at work, I enjoy spending time with my school-aged children. Dr. Patel is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Atherosclerosis, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Vijay Nambi, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Vijay Nambi specializes in Cardiology and works at BCM Medicine - Athero & Lipo. To make an appointment, please call (713) 798-5800. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Nambi is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Heart Failure, Peripheral Artery Disease, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Scott Solomon is a Cardiologist in Boston, Massachusetts. Dr. Solomon is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atherosclerosis, Heart Bypass Surgery, and Pacemaker Implantation.

Dr. Chiadi Ndumele is the Director of Obesity and Cardiometabolic Research, Director of the Heart Failure Prevention Program and Associate Professor of Medicine and Epidemiology in the Division of Cardiology at Johns Hopkins University. Dr. Ndumele is a preventive cardiologist with doctorate level training in epidemiology, who leads a research program related to characterizing the relationship of obesity and cardiometabolic risk factors with the development of cardiovascular disease, with a particular focus on heart failure risk, and to refining strategies for cardiovascular disease prevention. His work additionally addresses the impact of social determinants of health on cardiometabolic risk factors and downstream cardiovascular outcomes. Dr. Ndumele received his M.D. from Harvard University and his Internal Medicine training at Brigham and Women’s Hospital, where he also served as Chief Medical Resident. He subsequently trained in Cardiology at Johns Hopkins University, where he was also Chief Cardiology Fellow in his final year and where he also received his MHS and PhD in Epidemiology. Dr. Ndumele’s research has been supported by multiple grants from the NIH, Robert Wood Johnson Foundation and the American Heart Association (AHA). He is Chair of the Council on Lifestyle and Cardiometabolic Health of the AHA, Past Chair of the AHA Obesity Committee, and Co-Chair of the AHA Cardiovascular-Kidney-Metabolic Health Initiative. Dr. Ndumele is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Metabolic Syndrome.

Valentin Fuster is a Cardiologist in New York,, New York. Dr. Fuster is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Heart Attack, Coronary Heart Disease, Heart Bypass Surgery, and Percutaneous Coronary Intervention (PCI).

As a board-certified interventional cardiologist, Dr. Banerjee is internationally recognized for his expertise in minimally invasive treatments of coronary artery disease, peripheral artery disease and transcatheter aortic valve replacement. He is currently serving as the Paul J. Thomas Endowed Chair in Cardiology and chief of cardiovascular research and innovation for Baylor Scott & White Heart and Vascular Services-Dallas. Dr. Banerjee is the editor-in-chief of the American Journal of Cardiology, one of the premier cardiology journals in the world. He also serves as one of the founding directors of the Cardiovascular Innovations Foundation. He has led many landmark clinical trials, published over 450 peer-reviewed manuscripts, and is an invited faculty at national and international cardiovascular conferences. Dr. Banerjee is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Atherosclerosis, Coronary Heart Disease, Atherectomy, and Angioplasty.

Deepak Bhatt is a Cardiologist in New York, New York. Dr. Bhatt is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Heart Attack, Acute Coronary Syndrome, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Amir Lerman is a Cardiologist in Rochester, Minnesota. Dr. Lerman is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Angina, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Carotid Artery Surgery.

John Spertus is a Cardiologist in Kansas City,, Missouri. Dr. Spertus is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Angina, Heart Attack, Peripheral Artery Disease, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Eric Secemsky is a Cardiologist and an Internal Medicine provider in Boston, Massachusetts. Dr. Secemsky has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Pulmonary Embolism, Atherosclerosis, Angioplasty, and Embolectomy.

Muredach Reilly is a Cardiologist in New York, New York. Dr. Reilly is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Hypertrophic Cardiomyopathy (HCM), Coronary Heart Disease, Cardiomyopathy, and Heart Transplant. Dr. Reilly is currently accepting new patients.

Seth Martin is a Cardiologist in Lutherville, Maryland. Dr. Martin is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are High Cholesterol, Atherosclerosis, Heart Attack, Heart Bypass Surgery, and Pacemaker Implantation.

Dr. Bittencourt, MD, is the Director of Cardiac Computed Tomography at the Heart and Vascular Institute from UPMC Presbyterian and an Associate Professor of Medicine at the University of Pittsburgh. Dr. Bittencourt is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, High Cholesterol, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Andrew J.P. Klein, M.D., FACC, FSCAI, earned his bachelor's degree from University of Notre Dame and his medical degree from MCP Hahnemann School of Medicine in Philadelphia. He completed his residency in internal medicine at University of California San Francisco. He then completed fellowships in cardiovascular disease and interventional cardiology at University of Colorado Health Sciences and a fellowship in clinical research at the University of Wisconsin.Prior to joining Piedmont, Dr. Klein was in practice at the John Cochran VA Medical Center in St. Louis where he served as the Director of Cardiovascular Disease Research and the Director of the Endovascular Laboratory. While there, he was named for the last 3 years as one of St. Louis's Top Doctors by Saint Louis Magazine. Board certified in endovascular medicine, vascular medicine, interventional cardiology and cardiovascular diseases and internal medicine, Dr. Klein is an fellow of the American College of Cardiology (ACC) and Society for Cardiovascular Angiography and Intervention.(SCAI). An expert in complex coronary and peripheral intervention, he is a member of several SCAI committees.In his spare time, Dr. Klein enjoys spending time with family, including his spouse Christina Klein, M.D., who is a transplant physician at Piedmont, and their two beautiful children. Dr. Klein is an avid exercise fanatic having run several marathons and triathlons. He is also an outdoor enthusiast having backpacked across Joshua Tree National Park and summited Half Dome with Christina when they were residents together at UCSF. The entire Klein family are skiers and look forward to returning each year to the mountains for moguls, deep powder and glade skiing. Dr. Klein welcomes new patients and accepts most insurance plans. Dr. Klein is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Atherosclerosis, Coronary Heart Disease, Lithotripsy, and Embolectomy.